Professional
Added to YB: 2026-10-09
Pitch date: 2026-10-05
LOVE.TO [bullish]
Cannara Biotech Inc.
-6.85%
current return
Author Info
Atrium Research provides institutional quality research on underfollowed public equities. Sign up for the newsletter.
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 205.3M
Pitch Price
CAD 2.19
Price Target
3.00 (+47%)
Dividend
N/A
EV/EBITDA
8.82
P/E
18.92
EV/Sales
1.88
Sector
Personal Care Products
Category
growth
Cannara Biotech – Deepening Strategic Relationship with Curaleaf
LOVE.TO (hold): Cannara’s expanded Curaleaf supply agreement lifts potential two-year value 62% to $34M just two months after supply began, validating flower quality and strengthening the demand case. With 15 of 24 Valleyfield grow rooms active and the FY29 buildout fully funded, execution remains strong; LOVE trades at 6.0x 2027E EBITDA versus Curaleaf at 10.9x, with a maintained $3 target, though demand remains the principal capacity constraint.
Read full article (3 min)